Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...

There are so many water-access communities in the Lakes Region that provide great memories. Let’s take a look at Balmoral on ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.COWbVb-l.js ...

"The last four or five games here, we’re in those games. So it’s not like there have been just horrible blowouts." ...

A Gardner man is remembering his friend Alexandr Kirsanov, who was killed in the collision between American Airlines 5342 and ...

The Swiss pharmaceutical company said the FDA backed a label expansion for the Pathway HER2 (4B5) test to identify patients with HR-positive, HER2-ultralow metastatic breast cancer who could be ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...

As seen in the DESTINY-Breast06 trial, approximately 20-25 percent of hormone receptor (HR)-positive, HER2-negative breast ...

Sanofi SNY and Roche RHHBY announced their fourth-quarter and full-year 2024 results. Novo Nordisk’s NVO novel obesity ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

Chris Rocheleau, Trump’s pick for acting head of the Federal Aviation Administration, has been a longtime agency official and ...